|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Eptifibatide#Patient Counseling Information]] |
| {{Eptifibatide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Patient Counseling Information==
| |
| Instruct patients to inform the doctor or healthcare provider about any medical conditions, medications, and allergies.
| |
| | |
| Manufactured for: Merck Sharp & Dohme Corp., a subsidiary of
| |
| MERCK & CO., INC., Whitehouse Station, NJ 08889, USA
| |
| | |
| Manufactured by:
| |
| Patheon Italia S.p.A, Ferentino, 03013, Italy
| |
| | |
| U.S. Patent Nos. 5,686,570; 5,747,447; and 5,756,451.
| |
| | |
| INTEGRILIN is a registered trademark of Millennium Pharmaceuticals, Inc.
| |
| | |
| USPI-I-69361303R011<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad82e30-50d8-450c-8a2a-b4b507ed1ce2 | publisher = | date = | accessdate = 5 February 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |